FORM 4 U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
[ ] Check this box if OMB APPROVAL
no longer subject --------------------------
to Section 16. Form OMB Number 3235-0287
4 or Form 5 obliga- Expires: February 1, 1994
tions may continue. Estimated average burden
See Instruction 1(b). hours per response ... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of
1934, Section 17(a) of the Public Utility Holding Company Act
of 1935 or Section 30(1) of the Investment Company Act of 1940
--------------------------------------------------------------------------
1. Name and Address of Reporting Person
Daniel Glassman
383 Route 46 West
Fairfield, NJ 07004
--------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
BRADLEY PHARMACEUTICALS, INC. "BPRX"
--------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
--------------------------------------------------------------------------
4. Statement for Month/Year
9/97
--------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
--------------------------------------------------------------------------
6. Relationship of Reporting Person to Issuer (Check all applicable)
_X__ Director _X__ 10% Owner
X Officer (give title below) ___ Other (specify below)
---
Chairman, Pres. & CEO
--------------------------------------------------------------------------
TABLE 1 - NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF,
OR BENEFICIALLY OWNED
1. Title of 2. Transaction 3. Transaction 4. Securities
Security Date Code Acquired (A) or
(Instr.3) (Month/Day/ (Instr.8) Disposed of (D)
Year) (Instr.3,4,and 5)
--------------- --------------------
Code V Amount (A)or Price
(D)
---------------------------------------------------------------------------
A. Class A 9/22/97 T 11700 A $1.25
Common Stock
---------------------------------------------------------------------------
B. Class A 9/11/97 T 327 A $1.25
Common Stock
---------------------------------------------------------------------------
C. Class A 9/11/97 T 167 A $1.25
Common Stock
---------------------------------------------------------------------------
D. Class A 9/11/97 T 226 A $1.25
Common Stock
---------------------------------------------------------------------------
5. Amount of 6. Ownership 7. Nature of
Securities Form: Direct Indirect
Beneficially (D) or In- Beneficial
Owned at End direct (I) Ownership
of Month (Instr.4) (Instr.4)
(Instr.3 and 4)
---------------------------------------------------------------------------
A. 11700 I By wife
---------------------------------------------------------------------------
B. 327 I 401(K)
---------------------------------------------------------------------------
C. 167 I By children
---------------------------------------------------------------------------
D. 226 I By children
---------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities
beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction
4(b)(v).
(over)
<PAGE>
FORM 4 (Continued)
TABLE II - DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY
OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
1. Title of 2. Conversion or 3. Transaction 4. Transaction
Derivative Exercise Price Date (Month/ Code
Security of Derivative Day/Year) (Instr.8)
(Instr.3) Security ----------------
Code V
---------------------------------------------------------------------------
---------------------------------------------------------------------------
---------------------------------------------------------------------------
---------------------------------------------------------------------------
5. Number of 6. Date Exer- 7. Title and
Derivative cisable and Amount of
Securities Expiration Underlying
Acquired(A) Date (Month/ Securities
or Disposed Day/Year) (Instr.3 and 4)
of (D)(Instr.
3, 4, and 5)
----------------- ------------------ -----------------------
(A) (D) Date Expira- Title Amount or
Exer- tion Number of
cisable Date Shares
---------------------------------------------------------------------------
---------------------------------------------------------------------------
---------------------------------------------------------------------------
---------------------------------------------------------------------------
8. Price of 9. Number of 10. Ownership 11. Nature of
Derivative Derivative Form of Indirect
Security Securities Derivative Beneficial
(Instr.5) Beneficially Security: Ownership
Owned at End Direct (D) (Instr.4)
of Month or Indirect
(Instr.4) (I)(Instr.4)
---------------------------------------------------------------------------
---------------------------------------------------------------------------
---------------------------------------------------------------------------
---------------------------------------------------------------------------
EXPLANATION OF RESPONSES: *
by: /s/ Daniel Glassman September 24, 1997
--------------------------- -----------------
**SIGNATURE OF REPORTING PERSON DATE
Daniel Glassman
**INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACTS CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
NOTE: FILE THREE COPIES OF THIS FORM, ONE OF WHICH MUST BE MANUALLY SIGNED.
IF SPACED PROVIDED IS INSUFFICIENT, SEE INSTRUCTION 6 FOR PROCEDURE.
